Ivermectin has gained attention in the medical world. It happened because the medicine has shown a huge potential when it ...

In conclusion, this journey of discovery has taken us from the description of one ion channel to the clinical use of its inhibition, which has the potential to benefit millions of patients with ...

Ionis Pharmaceuticals (IONS) closed the last trading session at $38.26, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...

Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China State Key Laboratory of Petroleum Molecular & Process ...

Credit: Cyril Fresillon C2N Ion-X CNRS Images SAN FRANCISCO – French propulsion startup Ion-X raised 13 million euros ($13.67 million) in a Series A funding round announced Dec. 10. With the ...